Regeneration in the digestive tract / Antibiotics leave permanent traces in the gut

Public Release: 6-Nov-2018   Max Delbrück Center for Molecular Medicine in the Helmholtz Association The human gut is teeming with billions of beneficial bacteria. Therapies that use antibiotics often destroy most of them. Whether and how the intestinal flora will subsequently recover has been investigated by a research team that included scientists from the MDC.…

How to help protect yourself from vaccine administration injury

Public Release: 23-Oct-2018   University of Waterloo A study by researchers at the University of Waterloo reiterates the need for health care professionals, including pharmacists, to take certain precautions to minimize the risk of their patients suffering shoulder injury related to vaccine administration (SIRVA). SIRVA is an uncommon and understudied phenomenon that people may experience…

Researchers engineer dual vaccine against anthrax and plague

Public Release: 16-Oct-2018 American Society for Microbiology Washington, DC – October 16, 2018 – A team of researchers has now engineered a virus nanoparticle vaccine against Bacillus anthracis and Yersinia pestis, tier 1 agents that pose serious threats to national security of the United States. B. anthracis and Y. pestis are the pathogens that cause…

Higher levels of urinary fluoride associated with ADHD in children

Public Release: 10-Oct-2018 University of Toronto Higher levels of urinary fluoride associated with Attention Deficit Hyperactivity Disorder (ADHD) in children Higher levels of urinary fluoride during pregnancy are associated with more ADHD-like symptoms in school-age children, according to University of Toronto and York University researchers. “Our findings are consistent with a growing body of evidence…

Reclassification recommendations for drug in ‘magic mushrooms’

Public Release: 26-Sep-2018 If phase III clinical trials are successful, researchers suggest categorizing the drug as schedule IV Johns Hopkins Medicine In an evaluation of the safety and abuse research on the drug in hallucinogenic mushrooms, Johns Hopkins researchers suggest that if it clears phase III clinical trials, psilocybin should be re-categorized from a schedule…

The BMJ questions transparency of information surrounding safety of Pandemrix vaccine

Public Release: 20-Sep-2018 BMJ A series of internal GlaxoSmithKline reports suggest possibility that serious safety signal had emerged for Pandemrix during 2009 H1N1 vaccine campaigns Data indicated large discrepancies in rate of adverse event reporting for Pandemrix as compared to other GSK pandemic influenza vaccines Manufacturer and some public health bodies received reports but did…

Aspirin found not to prolong healthy aging

Public Release: 17-Sep-2018   Large, international study shows daily low-dose aspirin has no effect on healthy life span in older adults Rush University Medical Center Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial published online Sept.…

Vicious circle leads to loss of brain cells in old age

Public Release: 31-Aug-2018 Researchers at the University of Bonn determine how dangerous inflammations in the brain are caused University of Bonn IMAGE: Dr. Andras Bilkei-Gorzo and his colleagues have determined how endocannabinoids attenuate inflammatory reactions in the brain. Credit: © Photo: Kerstin Nicolai/Uni Bonn The so-called CB1 receptor is responsible for the intoxicating effect of…